2024 Research Achievements Summary of Professor Yunfeng Lin’s Team at Yunhai Bio

As we look back on 2024, it has been another remarkable year...

Learn More

Yunhai Bio: Empowering Traditional Chinese Medicine with Tetrahedral Framework Nucleic Acids, Pioneering the Modernization of TCM through Nanotechnology

Recently, Yunhai Bio has launched the groundbreaking "Qinghe...

Learn More

Yunhai Bio Launches First Consumer-Grade Product Based on Tetrahedral Framework Nucleic Acids A New Era of Hair Care Entering the Nanotechnology Age

Yunhai Bio’s first consumer-grade product based on Tetrahedr...

Learn More

Yunhai Biotech has been selected for the first batch of "Top Solver" projects at the National Precision Medicine Industry Innovation Center

On November 28, 2024, the Precision Medicine Industry Innova...

Learn More

Professor Yunfeng Lin of Yunhai Bio Invited to Attend the "Sci-Tech Tianfu · Intelligence Converges in Chengdu" Technology Achievements Docking Event

On November 18, 2024, the "Sci-Tech Tianfu – Intelligence Co...

Learn More

Tetrahedral Framework Nucleic Acid Blue Book Event Successfully Held

On November 8, 2024, Tetrahedral Framework Nucleic Acid Blue...

Learn More

tFNA + miRNA: A Breakthrough in Ophthalmic Treatment

In 2024, the Nobel Prize in Physiology or Medicine was award...

Learn More

AI-Assisted Nucleic Acid Drug Development

In a remarkable coincidence, the 2024 Nobel Prize in Physics...

Learn More

Professor Yunfeng Lin's Team Publishes Sichuan University's First Nature Protocols Paper of the Year!

Recently, Professor Yunfeng Lin’s team published a breakthro...

Learn More

6th Health and Wellness Innovation and Translation Academic Exchange: High-Quality Tetrahedral Framework Nucleic Acid Projects Draw Attention

On September 5-6, the 6th Health and Wellness Innovation and...

Learn More

Wakayama Medical University Data Center Visits Yunhai Bio to Explore New Chapter in Big Data Collaboration

Professor Toshio Shimokawa, Director of the Data Center at W...

Learn More

“STAR Forum” Spotlight: Framework Nucleic Acid Drug Development

Professor Yunfeng Lin, the Chief Scientist of Yunhai Biotech...

Learn More

Yunhai Tetrahedral Framework Nucleic Acids Unveiled at Beijing Science and Technology Expo

From July 13 to 16, the Chengdu Science and Technology Burea...

Learn More

Media Report on the Tetrahedral Framework Nucleic Acid Industry Development Forum

In 2024, the inaugural Tetrahedral Framework Nucleic Acid In...

Learn More

From Theoretical Foundations to Application Exploration: The Industrialization of "Tetrahedral Framework Nucleic Acids" in Progress

The tetrahedral framework nucleic acid is a nucleic acid mol...

Learn More

The First Tetrahedral Framework Nucleic Acid Industry Development Forum Held in Chengdu

July7, 2024The inaugural Tetrahedral Framework Nucleic Acid ...

Learn More

The First Academic Committee Meeting of the Tetrahedral Framework Nucleic Acid Joint Engineering Center Held Successfully

On the afternoon of July 6, 2024, the first Academic Committ...

Learn More

First Tetrahedral Framework Nucleic Acid Industry Development Forum | 5 Days to Go

Learn More

Yunhai Biotechnology and Sichuan University Establish Joint Laboratory for Tetrahedral Framework Nucleic Acid Technology

On May 20, 2024, Yunhai Biotechnology and SichuanUniversity ...

Learn More

Sichuan University and Yunhai Biotechnology Reach Patent Transfer Agreement

On May 14, 2024, Chengdu Yunhai Tetrahedral BiotechnologyCo....

Learn More